Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Ophthalmologist , Vitreoretinal Surgeon, talks about how diabetic retinopathy is caused in patients with diabetes as well as treatment and management strategies.

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

Our eyes are one of the most important organs of our body, and not only are they our tool to see the outside world, but they can also be a reflection of our health. Changes in our eyes are not always ...

UK: A large-scale real-world analysis has revealed that insulin pump therapy offers significant survival benefits and lowers ...

A new study published in the journal of Diabetes Research and Clinical Practice found that patients with type 1 and type 2 ...

Speaking to media on Tuesday, Dr Nadeem Qureshi, Head of the Retina Department at Al-Shifa Trust Eye Hospital, warned that ...

Shifa Trust (AST) has expressed profound concern over the escalating threat of Diabetic Retinopathy, attributing the rise to ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...